Literature DB >> 17327494

Congenic removal of a QTL for blood pressure attenuates infarct size produced by middle cerebral artery occlusion in hypertensive rats.

Hiroshi Yao1, Zong-Hu Cui, Junichi Masuda, Toru Nabika.   

Abstract

A genome-wide screen found a blood pressure quantitative trait locus (QTL) on rat chromosome 1 in stroke-prone spontaneously hypertensive rats of a Japanese colony (SHRSP/Izm). In the present study, we investigated the effects of congenic removal of this QTL from SHRSP/Izm on infarct size produced by middle cerebral artery (MCA) occlusion. To establish the congenic strain (SHRSPwch1.0), the blood pressure QTL was introgressed from Wistar-Kyoto (WKY)/Izm to SHRSP/Izm by repeated backcrossing. Male SHRSP/Izm [10-12 wk old (young adult) n = 8, 5 mo old (adult) n = 17] and SHRSPwch1.0 (young adult n = 7, adult n = 15) were randomly assigned to distal MCA occlusion. Resting mean arterial blood pressure (MABP) was 212 +/- 23 mmHg in adult SHRSPwch1.0, which was significantly lower than 241 +/- 22 mmHg in SHRSP/Izm. Infarct volume in the congenic rats was significantly decreased compared with that in SHRSP/Izm (66.4 +/- 21.5 mm(3) vs. 103.4 +/- 24.8 mm(3)). Cerebral blood flow (CBF), determined at collaterally-perfused cortex with laser-Doppler flowmetry after MCA occlusion, was significantly greater in adult SHRSPwch1.0 compared with CBF in adult SHRSP/Izm. In young adult rats, there were no significant differences in MABP or in infarct volume between SHRSPwch1.0 and SHRSP/Izm. The congenic removal of a blood pressure QTL lowered blood pressure and caused a substantial reduction in infarct volume (-36%) with increased collateral CBF after MCA occlusion in the congenic rat. We demonstrated for the first time that the congenic strategy is useful to investigate the effects of genetic hypertension on focal ischemia or stroke.

Entities:  

Mesh:

Year:  2007        PMID: 17327494     DOI: 10.1152/physiolgenomics.00149.2006

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  8 in total

1.  Closely linked non-additive blood pressure quantitative trait loci.

Authors:  Edward J Toland; Yasser Saad; Shane Yerga-Woolwine; Steven Ummel; Phyllis Farms; Ramona Ramdath; Bryan C Frank; Norman H Lee; Bina Joe
Journal:  Mamm Genome       Date:  2008-03-07       Impact factor: 2.957

2.  Natural allelic variation of the IL-21 receptor modulates ischemic stroke infarct volume.

Authors:  Han Kyu Lee; Sehoon Keum; Huaxin Sheng; David S Warner; Donald C Lo; Douglas A Marchuk
Journal:  J Clin Invest       Date:  2016-07-11       Impact factor: 14.808

3.  Genetic architecture underlying variation in extent and remodeling of the collateral circulation.

Authors:  Shiliang Wang; Hua Zhang; Xuming Dai; Robert Sealock; James E Faber
Journal:  Circ Res       Date:  2010-06-24       Impact factor: 17.367

4.  Characterizing photothrombotic distal middle cerebral artery occlusion and YAG laser-induced reperfusion model in the Izumo strain of spontaneously hypertensive rats.

Authors:  Hiroshi Yao; Toru Nabika
Journal:  Cell Mol Neurobiol       Date:  2010-08-12       Impact factor: 5.046

5.  A locus mapping to mouse chromosome 7 determines infarct volume in a mouse model of ischemic stroke.

Authors:  Sehoon Keum; Douglas A Marchuk
Journal:  Circ Cardiovasc Genet       Date:  2009-10-19

Review 6.  Standards and pitfalls of focal ischemia models in spontaneously hypertensive rats: with a systematic review of recent articles.

Authors:  Hiroshi Yao; Toru Nabika
Journal:  J Transl Med       Date:  2012-07-06       Impact factor: 5.531

7.  Focal Ischemic Injury with Complex Middle Cerebral Artery in Stroke-Prone Spontaneously Hypertensive Rats with Loss-Of-Function in NADPH Oxidases.

Authors:  Hiroshi Yao; Mohammed Zubaerul Ferdaus; Hasan Md Zahid; Hiroki Ohara; Tatsuo Nakahara; Toru Nabika
Journal:  PLoS One       Date:  2015-09-21       Impact factor: 3.240

Review 8.  NADPH Oxidase-Related Pathophysiology in Experimental Models of Stroke.

Authors:  Hiroshi Yao; Tetsuro Ago; Takanari Kitazono; Toru Nabika
Journal:  Int J Mol Sci       Date:  2017-10-11       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.